February 03, 2026 11:29 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
After Budget mayhem, bulls return: Sensex, Nifty stage sharp recovery | Dalai Lama wins first Grammy at 90 | Firing outside Rohit Shetty’s Mumbai home: 4 arrested, Bishnoi Gang link emerges | Female suicide attackers emerge at centre of deadly BLA assaults that rocked Pakistan’s Balochistan | Delhi blast: Probe reveals doctors' module planned attacks on global coffee chain | Begging bowl: Pakistan PM says he feels “ashamed” seeking loans abroad | Epstein Files shocker! Zohran Mamdani’s mother Mira Nair mentioned in latest tranche | Bill Gates contracted STD after sex with Russian women? Epstein Files make explosive, unverified claims | Big setback for Modi govt: Supreme Court stays controversial UGC Equity Regulations 2026 amid student protests | ‘Mother of all deals’: PM Modi says India–EU FTA is for 'ambitious India'
PakVac

PakVac: Pakistan creates own COVID-19 vaccine with Chinese help

| @indiablooms | Jun 02, 2021, at 10:51 pm

Islamabad: Pakistan joined China's Cansino Bio to develop its own homemade COVID-19 vaccine named PakVac.

Pakistan has witnessed deadly COVID-19 pandemic waves which left at least 20,930 dead.

Pakistan on Tuesday inaugurated an antisera processing plant and launched 120,000 doses of PakVac produced from the concentrate of Cansino vaccine while the World Health Organisation (WHO) validated the emergency use of Sinovac vaccine, reports Dawn News.

National Institute of Health (NIH) Executive Director Maj Gen Prof Aamer Ikram, who attended the launch ceremony, told Dawn News that 120,000 doses were ready for use and the concentrate to produce 900,000 more doses had been procured.

“We held clinical trial with CanSinoBio in Pakistan and also made an agreement with it for technology transfer. We have been aiming to produce as many as three million doses every month as well as the raw material in future,” he added.

Prof Ikram said it was a big success as the vaccine was produced through an antisera production plant which was Good Manufacturing Practice (GMP) qualified and International Organisation for Standardisation (ISO) certified.

“We have also repaired two already available filling plants due to which we can further enhance the production of vaccine. Moreover, we will also be self-sufficient in the production of vaccines for measles, cholera and typhoid,” he added.

Special Assistant to Prime Minister on Health Dr Faisal Sultan wrote on his official Twitter handle: " Congratulations to the NIH Pak team and its leadership for successful fill/finish (from concentrate) of the Cansino vaccine with the help of Cansino Bio Inc. China. The product has passed the rigorous internal QA testing. An imp step to help in our vaccine supply line."

Image:  Faisal Sultan Twitter page

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.